Jin Yang Pharmaceutical Statistics

Total Valuation

Jin Yang Pharmaceutical has a market cap or net worth of KRW 58.68 billion. The enterprise value is 73.00 billion.

Market Cap	58.68B
Enterprise Value	73.00B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Jin Yang Pharmaceutical has 11.35 million shares outstanding. The number of shares has increased by 0.93% in one year.

Shares Outstanding	11.35M
Shares Change (YoY)	+0.93%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	31.83%
Owned by Institutions (%)	0.00%
Float	7.74M

Valuation Ratios

The trailing PE ratio is 6.77.

PE Ratio	6.77
Forward PE	n/a
PS Ratio	0.54
PB Ratio	0.60
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.91, with an EV/FCF ratio of -19.35.

EV / Earnings	7.44
EV / Sales	0.70
EV / EBITDA	7.91
EV / EBIT	11.18
EV / FCF	-19.35

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.20.

Current Ratio	1.38
Quick Ratio	0.81
Debt / Equity	0.20
Debt / EBITDA	2.00
Debt / FCF	-4.89
Interest Coverage	4.39

Financial Efficiency

Return on equity (ROE) is 11.18% and return on invested capital (ROIC) is 3.99%.

Return on Equity (ROE)	11.18%
Return on Assets (ROA)	3.23%
Return on Capital (ROIC)	3.99%
Revenue Per Employee	470.92M
Profits Per Employee	44.58M
Employee Count	220
Asset Turnover	0.82
Inventory Turnover	2.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-13.09%
50-Day Moving Average	5,544.20
200-Day Moving Average	5,673.55
Relative Strength Index (RSI)	41.54
Average Volume (20 Days)	57,543

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jin Yang Pharmaceutical had revenue of KRW 103.60 billion and earned 9.81 billion in profits. Earnings per share was 763.61.

Revenue	103.60B
Gross Profit	63.64B
Operating Income	6.53B
Pretax Income	10.38B
Net Income	9.81B
EBITDA	9.23B
EBIT	6.53B
Earnings Per Share (EPS)	763.61

Full Income Statement

Balance Sheet

The company has 4.14 billion in cash and 18.46 billion in debt, giving a net cash position of -14.32 billion or -1,261.71 per share.

Cash & Cash Equivalents	4.14B
Total Debt	18.46B
Net Cash	-14.32B
Net Cash Per Share	-1,261.71
Equity (Book Value)	92.86B
Book Value Per Share	8,603.97
Working Capital	12.13B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.60 billion and capital expenditures -16.37 billion, giving a free cash flow of -3.77 billion.

Operating Cash Flow	12.60B
Capital Expenditures	-16.37B
Free Cash Flow	-3.77B
FCF Per Share	-332.31

Full Cash Flow Statement

Margins

Gross margin is 61.43%, with operating and profit margins of 6.30% and 9.47%.

Gross Margin	61.43%
Operating Margin	6.30%
Pretax Margin	10.02%
Profit Margin	9.47%
EBITDA Margin	8.91%
EBIT Margin	6.30%
FCF Margin	-3.64%

Dividends & Yields

This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 2.90%.

Dividend Per Share	150.00
Dividend Yield	2.90%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	16.51%
Buyback Yield	-0.93%
Shareholder Yield	1.97%
Earnings Yield	14.77%
FCF Yield	-6.43%

Dividend Details

Stock Splits

The last stock split was on April 21, 2005. It was a forward split with a ratio of 10.

Last Split Date	Apr 21, 2005
Split Type	Forward
Split Ratio	10

Scores

Jin Yang Pharmaceutical has an Altman Z-Score of 2.76. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.76
Piotroski F-Score	n/a